Lung-RADS is the scoring system radiologists use to report lung cancer screening CT scans. Each scan gets a category, from 0 (incomplete) through 1 and 2 (negative or benign-looking) to 3 and 4 (probably benign to suspicious), and each category comes with a recommended next step, such as a routine yearly scan, a short-term follow-up scan or further tests.
Origin
The American College of Radiology released Lung-RADS in 2014, modeled on the breast-imaging BI-RADS system, to make screening reports consistent and reduce unnecessary follow-up. It has been updated since, most recently in a 2022 version.
Significance in Asbestos Context
For an asbestos-exposed person in a screening program, the Lung-RADS category is the key line in the report. Category 1 or 2 usually means returning for the next yearly scan. Category 3 generally means a repeat scan in about six months. Category 4A, 4B or 4X means the finding is suspicious, and the next step may be a short-interval CT, a PET-CT or a biopsy. Most nodules found on screening are not cancer, so a higher category is a reason for prompt follow-up rather than a diagnosis. An "S" added to the category flags a significant finding other than lung cancer, which can include pleural plaques, fibrosis or a pleural effusion, findings relevant to asbestos disease. For a claim, a sequence of Lung-RADS reports can show when a nodule was first seen and how it changed, which can matter for dates of diagnosis and limitations periods.
Example Sentence
His screening CT was scored Lung-RADS 4A because of a new 9-millimeter solid nodule, with an "S" modifier for calcified pleural plaques.
Related Terms
Low-Dose CT Screening, Lung Cancer, CT Scan, PET-CT, Pleural Plaques, Biopsy
Notes
- Ask what your Lung-RADS category is and what follow-up it calls for, and keep to the schedule.
- Ask whether an "S" modifier was added and what it refers to.
- Keep every screening report; changes from one year to the next are important to your doctors.
In the research library
2 studies in our medical research library mention Lung-RADS in the title or abstract. Among the most cited:
- Lung Cancer Screening in Individuals With and Without Lung-Related ComorbiditiesE.M. Metwally, M.P. Rivera, D.D. Durham, et al, 2022 · JAMA Network Open · cited 20 times
- Two-Phase Occupational Screening in Coal-Fired Power Plant Workers: Anamnestic Risk Stratification and Targeted Low-Dose CT FindingsA. Cranta, E. Osiac, D.I. Gheonea, et al, 2026 · Diagnostics
The journals that publish most on it: JAMA Network Open (1), Diagnostics (1).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.